SCHEMBL30597529

SCHEMBL30597529

Cc1cc(C)c2sc(NC(=O)C3CCN(C(=O)OC(C)(C)C)CC3)nc2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.69
▸ NPC1 O15118 3/20 0.69
▸ RAB9A P51151 3/20 0.69
▸ MEN1 O00255 2/20 0.69
▸ PTPN2 P17706 1/20 0.52
▸ PTPN1 P18031 1/20 0.52
▸ PTPN6 P29350 1/20 0.52
▸ EPHX2 P34913 2/20 0.52
▸ L3MBTL1 Q9Y468 2/20 0.52
▸ MAPT P10636 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ ABL1 P00519 1/20 0.46
▸ RIN1 Q13671 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.45
▸ LCK P06239 1/20 0.45
▸ STS P08842 3/20 0.44
▸ CLK1 P49759 1/20 0.44
▸ LMNA P02545 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30597527 0.85 NPC1 (0.54) KMT2ANPC1RAB9AMEN1PTPN2
SCHEMBL26458871 0.83 NPC1 (1.00) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL30597547 0.79 NPC1 (0.85) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL4396712 0.78 MAOA (0.64) KMT2ANPC1RAB9AMEN1PTPN2
SCHEMBL5578506 0.76 PTPN2 (0.56) KMT2ANPC1RAB9APTPN2PTPN1
SCHEMBL30597542 0.76 KMT2A (0.67) KMT2ANPC1RAB9AMEN1EPHX2
SCHEMBL30597513 0.75 MEN1 (0.63) KMT2ANPC1RAB9AMEN1EPHX2
SCHEMBL27311841 0.74 L3MBTL1 (0.53) KMT2ANPC1RAB9AMEN1PTPN2
SCHEMBL31420261 0.74 PTPN2 (0.48) KMT2ANPC1RAB9AMEN1PTPN2
SCHEMBL30597552 0.74 NPC1 (0.61) KMT2ANPC1RAB9AMEN1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250250265-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF NACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D VANDERBILT UNIVERSITY 2025-08-07 — — US disclosed
WO-2023201014-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF N-ACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D VANDERBILT UNIVERSITY (US) 2023-10-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250265-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF NACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D PLD1, PLD2, NAPEPLD KMT2A 1305/4885NPC1 1992/4885RAB9A 1483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback